Literature DB >> 7715985

Hospitalizations for respiratory syncytial virus infection in Alaska Native children.

R J Singleton1, K M Petersen, J E Berner, E Schulte, K Chiu, C M Lilly, E A Hughes, L R Bulkow, T L Nix.   

Abstract

To characterize the epidemiology of Alaska Native children hospitalized for respiratory syncytial virus infections, we reviewed records of hospitalizations during the winter seasons of 1991 to 1992 and 1992 to 1993 at a hospital in Anchorage and a rural hospital in the Yukon Kuskokwim Delta (YKD) region of southwestern Alaska. The median age of hospitalization for respiratory syncytial virus infection was 2 months of age for YKD residents and 4.5 months for Anchorage residents. Sixteen percent of the hospitalized YKD children were less than 1 month of age, whereas the same was true for only 3% of the Anchorage children. Eight percent of the YKD patients required mechanical ventilation, whereas none of the Anchorage patients required ventilation. The median hospital stay was 4.8 days for YKD patients and 3.2 days for Anchorage patients. Hospitalization rates for infants less than 1 year of age were 33/1000 for Alaska Natives in Anchorage and 100/1000 for those in the YKD region. The extremely high hospitalization rate, especially among very young infants in the rural YKD region, points to a need for early preventive efforts.

Entities:  

Mesh:

Year:  1995        PMID: 7715985     DOI: 10.1097/00006454-199501000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  Net cost of palivizumab for respiratory syncytial virus prophylaxis during the 1998/99 season in northern Alberta.

Authors:  S L Lee; P Etches; J L Robinson
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

2.  Local variability in respiratory syncytial virus disease severity.

Authors:  A H Brandenburg; P Y Jeannet; H A Steensel-Moll; A Ott; P H Rothbarth; W Wunderli; S Suter; H J Neijens; A D Osterhaus; C A Siegrist
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

3.  Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study.

Authors:  Anna Banerji; Val Panzov; Michael Young; Joan Robinson; Bonita Lee; Theo Moraes; Muhammad Mamdani; B Louise Giles; Depeng Jiang; Danny Bisson; Marguerite Dennis; Johanne Morel; Judith Hall; Charles Hui; Bosco Paes; James B Mahony
Journal:  CMAJ Open       Date:  2016-10-17

4.  Lower respiratory tract infections in Inuit infants on Baffin Island.

Authors:  A Banerji; A Bell; E L Mills; J McDonald; K Subbarao; G Stark; N Eynon; V G Loo
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

5.  Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.

Authors:  Lindsay Kim; Brian Rha; Jon S Abramson; Larry J Anderson; Carrie L Byington; Grace L Chen; John DeVincenzo; Kathryn M Edwards; Janet A Englund; Ann R Falsey; Marie R Griffin; Ruth A Karron; Karen G Martin; H Cody Meissner; Flor M Munoz; Andrew T Pavia; Pedro A Piedra; William Schaffner; Eric A F Simões; Rosalyn Singleton; H Keipp Talbot; Edward E Walsh; Jane R Zucker; Susan I Gerber
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

6.  The real-life effectiveness of palivizumab for reducing hospital admissions for respiratory syncytial virus in infants residing in Nunavut.

Authors:  Anna Banerji; Vladimir Panzov; Michael Young; Bonita E Lee; Muhammad Mamdani; B Louise Giles; Marguerite Dennis; Johanne Morel; Danny Bisson; Bosco A Paes; Charles Hui; Jim Mahony
Journal:  Can Respir J       Date:  2013-12-23       Impact factor: 2.409

7.  Epidemiology of respiratory syncytial virus infection in preterm infants.

Authors:  Bernhard Resch; Stefan Kurath; Paolo Manzoni
Journal:  Open Microbiol J       Date:  2011-12-30

8.  Transplacental transfer of RSV antibody in Australian First Nations infants.

Authors:  Nusrat Homaira; Michael Binks; Gregory Walker; Natasha Larter; Katrina Clark; Megan Campbell; Lisa McHugh; Nancy Briggs; Joyce Nyiro; Sacha Stelzer-Braid; Nan Hu; Kristine Macartney; Tom Snelling; Saad B Omer; William Rawlinson; Ross Andrews; Adam Jaffe
Journal:  J Med Virol       Date:  2021-10-16       Impact factor: 20.693

9.  Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, Italy.

Authors:  Paola Di Carlo; Amelia Romano; Ludovico Salsa; Alessandra Gueli; Antonella Poma; Fortunata Fucà; Piera Dones; Mirella Collura; Diego Pampinella; Delia Motisi; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2009-05-02       Impact factor: 2.638

10.  Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.

Authors:  Helen Y Chu; James Tielsch; Joanne Katz; Amalia S Magaret; Subarna Khatry; Stephen C LeClerq; Laxman Shrestha; Jane Kuypers; Mark C Steinhoff; Janet A Englund
Journal:  J Clin Virol       Date:  2017-09-02       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.